Masuuma Namjoshi – Criticare Asia Multispeciality Hospitals And Research Center

• Masuuma Namjoshi co-founded Criticare Asia Multispeciality Hospitals in 1999, contributing to the establishment of a healthcare institution aimed at providing comprehensive medical services.
• The hospital has expanded its services to include a variety of specialties, increasing access to quality healthcare for the community.
• Under Namjoshi's leadership, Criticare Asia has implemented advanced medical technologies, improving patient care and operational efficiency.
• Namjoshi played a pivotal role in developing partnerships with other healthcare providers and organizations, enhancing the hospital's resources and service offerings.
• The organization emphasizes research and innovation, with initiatives led by Namjoshi focusing on advancing medical practices and healthcare delivery.
• Criticare Asia has received various certifications and accolades, reflecting its commitment to quality and excellence in healthcare.
• Namjoshi has advocated for patient-centered care, ensuring that healthcare services meet the needs and preferences of patients.
• Throughout the years, Criticare Asia has responded to healthcare challenges, including public health crises, showcasing resilience and adaptability in the face of adversity.

Professional Experience

Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)

Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.

Official Email: Via Criticare Asia Multispeciality Hospitals And Research Center corporate communication desk.

Personal Contact: Not publicly disclosed.

What is Masuuma Namjoshi's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).

How can I contact them?
Through Criticare Asia Multispeciality Hospitals And Research Center's official communication channels.

Is this an official profile?
No — independently created using public data.

This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.

Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.

Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.

Affluense AI – Smarter Insights. Stronger Relationships with Affluents.

Last Updated: December 2025 · Published by Affluense AI (affluense.ai)